As of the latest SEC filings, Liminatus Pharma, Inc. (LIMNW) is held by 2 institutional funds. The largest fund shareholder is Saba Capital Income & Opportunities Fund (BRW), holding an estimated $1,672.05 in market value, representing a significant portion of its portfolio.